{"nct_id":"NCT01647828","title":"A Phase 1b/2 Study of OMP-59R5 (Tarextumab) in Combination With Nab-Paclitaxel and Gemcitabine in Subjects With Previously Untreated Stage IV Pancreatic Cancer","status":"COMPLETED","status_verified_date":"2023-01","start_date":"2012-10","start_date_type":null,"primary_completion_date":"2016-04","primary_completion_date_type":"ACTUAL","completion_date":"2016-04","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["MREO"]}